{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:15:34Z","timestamp":1792124134266,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["2005-2-14373"],"award-info":[{"award-number":["2005-2-14373"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["2009-1-111384"],"award-info":[{"award-number":["2009-1-111384"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["2010-1-140962"],"award-info":[{"award-number":["2010-1-140962"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["2016-272632"],"award-info":[{"award-number":["2016-272632"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10549-020-05562-0","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T02:02:25Z","timestamp":1582336945000},"page":"791-800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A cumulative index of exposure to endogenous estrogens and breast cancer by molecular subtypes in northern Mexican women"],"prefix":"10.1007","volume":"180","author":[{"given":"Elodia","family":"Rojas-Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Gamboa-Loira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano E.","family":"Cebri\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Rothenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3245-8337","authenticated-orcid":false,"given":"Lizbeth","family":"L\u00f3pez-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,22]]},"reference":[{"key":"5562_CR1","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.7150\/jca.13141","volume":"7","author":"X Dai","year":"2016","unstructured":"Dai X, Xiang L, Li T, Bai Z (2016) Cancer hallmarks, biomarkers and breast cancer molecular subtypes. J Cancer 7:1281\u20131294. https:\/\/doi.org\/10.7150\/jca.13141","journal-title":"J Cancer"},{"key":"5562_CR2","doi-asserted-by":"publisher","first-page":"e1000279","DOI":"10.1371\/journal.pmed.1000279.g003","volume":"7","author":"FM Blows","year":"2010","unstructured":"Blows FM, Driver KE, Schmidt MK et al (2010) Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 7:e1000279. https:\/\/doi.org\/10.1371\/journal.pmed.1000279.g003","journal-title":"PLoS Med"},{"key":"5562_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3322\/caac.21412","volume":"67","author":"CE DeSantis","year":"2017","unstructured":"DeSantis CE, Ma J, Goding Sauer A et al (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67:439\u2013448. https:\/\/doi.org\/10.3322\/caac.21412","journal-title":"CA Cancer J Clin"},{"key":"5562_CR4","doi-asserted-by":"publisher","first-page":"dju055","DOI":"10.1093\/jnci\/dju055","volume":"106","author":"N Howlader","year":"2014","unstructured":"Howlader N, Altekruse SF, Li CI et al (2014) US Incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 106:dju055. https:\/\/doi.org\/10.1093\/jnci\/dju055","journal-title":"J Natl Cancer Inst"},{"key":"5562_CR5","doi-asserted-by":"publisher","first-page":"13109","DOI":"10.1038\/s41598-018-31393-7","volume":"8","author":"I Romieu","year":"2018","unstructured":"Romieu I, Biessy C, Carayol M et al (2018) Reproductive factors and molecular subtypes of breast cancer among premenopausal women in Latin America: the PRECAMA study. Sci Rep 8:13109. https:\/\/doi.org\/10.1038\/s41598-018-31393-7","journal-title":"Sci Rep"},{"key":"5562_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.5114\/wo.2015.56652","volume":"19","author":"G P\u00e9rez-Rodr\u00edguez","year":"2015","unstructured":"P\u00e9rez-Rodr\u00edguez G, Aranda-Moreno C, Olivares-Corichi IM, Garcia-Sanchez JR (2015) The association of subtypes of breast cancer with tumour characteristics and reproductive factors in 1326 Mexican women. Contemp Oncol (Pozn) 19:462\u2013466. https:\/\/doi.org\/10.5114\/wo.2015.56652","journal-title":"Contemp Oncol (Pozn)"},{"key":"5562_CR7","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/bcr2124","volume":"10","author":"P Wirapati","year":"2008","unstructured":"Wirapati P, Sotiriou C, Kunkel S et al (2008) Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 10:R65. https:\/\/doi.org\/10.1186\/bcr2124","journal-title":"Breast Cancer Res"},{"key":"5562_CR8","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1186\/bcr1525","volume":"8","author":"H Ma","year":"2006","unstructured":"Ma H, Bernstein L, Pike MC, Ursin G (2006) Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 8:R43. https:\/\/doi.org\/10.1186\/bcr1525","journal-title":"Breast Cancer Res"},{"key":"5562_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jnci\/djq526","volume":"103","author":"XR Yang","year":"2011","unstructured":"Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 103:250\u2013263. https:\/\/doi.org\/10.1093\/jnci\/djq526","journal-title":"J Natl Cancer Inst"},{"key":"5562_CR10","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/ijc.29968","volume":"138","author":"JS Sisti","year":"2016","unstructured":"Sisti JS, Collins LC, Beck AH et al (2016) Reproductive risk factors in relation to molecular subtypes of breast cancer: results from the Nurses\u2019 Health Studies HHS Public Access. Int J Cancer 138:2346\u20132356. https:\/\/doi.org\/10.1002\/ijc.29968","journal-title":"Int J Cancer"},{"key":"5562_CR11","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1158\/0008-5472.CAN-16-2574","volume":"77","author":"J Holm","year":"2017","unstructured":"Holm J, Eriksson L, Ploner A et al (2017) Assessment of breast cancer risk factors reveals subtype heterogeneity. Cancer Res 77:3708\u20133717. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2574","journal-title":"Cancer Res"},{"key":"5562_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ctrv.2016.07.006","volume":"49","author":"M Lambertini","year":"2016","unstructured":"Lambertini M, Santoro L, Del Mastro L et al (2016) Reproductive behaviors and risk of developing breast cancer according to tumor subtype: a systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev 49:65\u201376. https:\/\/doi.org\/10.1016\/j.ctrv.2016.07.006","journal-title":"Cancer Treat Rev"},{"key":"5562_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13058-016-0798-x","volume":"19","author":"M Ellingjord-Dale","year":"2017","unstructured":"Ellingjord-Dale M, Vos L, Tretli S et al (2017) Parity, hormones and breast cancer subtypes: results from a large nested case\u2013control study in a national screening program. Breast Cancer Res 19:10. https:\/\/doi.org\/10.1186\/s13058-016-0798-x","journal-title":"Breast Cancer Res"},{"key":"5562_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10552-007-9098-1","volume":"19","author":"C Sweeney","year":"2008","unstructured":"Sweeney C, Baumgartner KB, Byers T et al (2008) Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women. Cancer Causes Control 19:391\u2013401. https:\/\/doi.org\/10.1007\/s10552-007-9098-1","journal-title":"Cancer Causes Control"},{"key":"5562_CR15","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/cncr.23786","volume":"113","author":"AI Phipps","year":"2008","unstructured":"Phipps AI, Malone KE, Porter PL et al (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113:1521\u20131526. https:\/\/doi.org\/10.1002\/cncr.23786","journal-title":"Cancer"},{"key":"5562_CR16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S0140-6736(17)30573-1","volume":"390","author":"G Jasienska","year":"2017","unstructured":"Jasienska G, Bribiescas RG, Furberg AS et al (2017) Human reproduction and health: an evolutionary perspective. Lancet 390:510\u2013520. https:\/\/doi.org\/10.1016\/S0140-6736(17)30573-1","journal-title":"Lancet"},{"key":"5562_CR17","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"MEH Hammond","year":"2010","unstructured":"Hammond MEH, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784\u20132795. https:\/\/doi.org\/10.1200\/JCO.2009.25.6529","journal-title":"J Clin Oncol"},{"key":"5562_CR18","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond MEH, Hicks DG et al (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast: American Society of Clinical Oncology\/College of American Pathologist Clinical Practice Guideline Update. J Clin Oncol 31:3997\u20134013. https:\/\/doi.org\/10.1200\/JCO.2013.50.9984","journal-title":"J Clin Oncol"},{"key":"5562_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.taap.2014.07.013","volume":"280","author":"L L\u00f3pez-Carrillo","year":"2014","unstructured":"L\u00f3pez-Carrillo L, Hern\u00e1ndez-Ram\u00edrez RU, Gandolfi AJ et al (2014) Arsenic methylation capacity is associated with breast cancer in Northern Mexico. Toxicol Appl Pharmacol 280:53\u201359. https:\/\/doi.org\/10.1016\/j.taap.2014.07.013","journal-title":"Toxicol Appl Pharmacol"},{"key":"5562_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.je.2016.05.002","volume":"27","author":"H Li","year":"2017","unstructured":"Li H, Sun X, Miller E et al (2017) BMI, reproductive factors, and breast cancer molecular subtypes: a case\u2013control study and meta-analysis. J Epidemiol 27:143\u2013151. https:\/\/doi.org\/10.1016\/j.je.2016.05.002","journal-title":"J Epidemiol"},{"key":"5562_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00781","author":"R Girgert","year":"2019","unstructured":"Girgert R, Emons G, Gr\u00fcndker C (2019) Estrogen signaling in ER\u03b1-negative breast cancer: ER\u03b2 and GPER. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2018.00781","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5562_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1210\/me.2009-0148","volume":"24","author":"Y Li","year":"2010","unstructured":"Li Y, Birnbaumer L, Teng CT (2010) Regulation of ERRa gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by G protein-coupled receptor GPR30\/GPER-1. Mol Endocrinol 24:969\u2013980. https:\/\/doi.org\/10.1210\/me.2009-0148","journal-title":"Mol Endocrinol"},{"key":"5562_CR23","doi-asserted-by":"publisher","first-page":"10277","DOI":"10.1158\/0008-5472.CAN-10-2840","volume":"70","author":"G Deblois","year":"2010","unstructured":"Deblois G, Chahrour G, Perry MC et al (2010) Transcriptional control of the ERBB2 amplicon by ERRa and PGC-1b promotes mammary gland tumorigenesis. Cancer Res 70:10277\u201310287. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2840","journal-title":"Cancer Res"},{"key":"5562_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10911-014-9329-5","volume":"19","author":"A Dittrich","year":"2014","unstructured":"Dittrich A, Gautrey H, Browell D, Tyson-Capper A (2014) The HER2 signaling network in breast cancer: like a spider in its web. J Mammary Gland Biol Neoplasia 19:253\u2013270. https:\/\/doi.org\/10.1007\/s10911-014-9329-5","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"5562_CR25","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.bbamcr.2019.05.003","volume":"1866","author":"Z Culig","year":"2019","unstructured":"Culig Z (2019) Epithelial mesenchymal transition and resistance in endocrine-related cancers. Biochim Biophys Acta Mol Cell Res 1866:1368\u20131375. https:\/\/doi.org\/10.1016\/j.bbamcr.2019.05.003","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"5562_CR26","doi-asserted-by":"publisher","DOI":"10.20517\/2394-4722.2019.01","author":"TR Wallace","year":"2019","unstructured":"Wallace TR, Tarullo SE, Crump LS, Lyons TR (2019) Studies of postpartum mammary gland involution reveal novel pro-metastatic mechanisms. J Cancer Metastasis Treat. https:\/\/doi.org\/10.20517\/2394-4722.2019.01","journal-title":"J Cancer Metastasis Treat"},{"key":"5562_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.maturitas.2004.04.011","volume":"49","author":"J Russo","year":"2004","unstructured":"Russo J, RussoIrma H (2004) Development of the human breast. Maturitas 49:2\u201315. https:\/\/doi.org\/10.1016\/j.maturitas.2004.04.011","journal-title":"Maturitas"},{"key":"5562_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ygyno.2004.11.038","volume":"96","author":"RM Merrill","year":"2005","unstructured":"Merrill RM, Fugal S, Novilla LB, Raphael MC (2005) Cancer risk associated with early and late maternal age at first birth. Gynecol Oncol 96:583\u2013593. https:\/\/doi.org\/10.1016\/j.ygyno.2004.11.038","journal-title":"Gynecol Oncol"},{"key":"5562_CR29","doi-asserted-by":"crossref","first-page":"53941","DOI":"10.18632\/oncotarget.9690","volume":"7","author":"WM Elshmay","year":"2016","unstructured":"Elshmay WM (2016) The protective effect of longer duration of breastfeeding against pregnancy-associated triple negative breast cancer. Oncotarget 7:53941\u201353950","journal-title":"Oncotarget"},{"key":"5562_CR30","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1158\/0008-5472.CAN-18-0502","volume":"78","author":"MM Gaudet","year":"2018","unstructured":"Gaudet MM, Gierach GL, Carter BD et al (2018) Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype. Cancer Res 78:6011\u20136021. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0502","journal-title":"Cancer Res"},{"key":"5562_CR31","doi-asserted-by":"publisher","first-page":"e3063","DOI":"10.1097\/MD.0000000000003063","volume":"95","author":"B Park","year":"2016","unstructured":"Park B, Choi J-Y, Sung HK et al (2016) Attribution to heterogeneous risk factors for breast cancer subtypes based on hormone receptor and human epidermal growth factor 2 receptor expression in Korea. Medicine (Baltimore) 95:e3063. https:\/\/doi.org\/10.1097\/MD.0000000000003063","journal-title":"Medicine (Baltimore)"},{"key":"5562_CR32","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s12032-009-9308-7","volume":"27","author":"P Xing","year":"2010","unstructured":"Xing P, Li J, Jin F (2010) A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol 27:926\u2013931. https:\/\/doi.org\/10.1007\/s12032-009-9308-7","journal-title":"Med Oncol"},{"key":"5562_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/jnci\/djr030","volume":"103","author":"AI Phipps","year":"2011","unstructured":"Phipps AI, Chlebowski RT, Prentice R et al (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103:470\u2013477. https:\/\/doi.org\/10.1093\/jnci\/djr030","journal-title":"J Natl Cancer Inst"},{"key":"5562_CR34","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1093\/annonc\/mdr613","volume":"23","author":"T Islam","year":"2012","unstructured":"Islam T, Matsuo K, Ito H et al (2012) Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women. Ann Oncol 23:2435\u20132441. https:\/\/doi.org\/10.1093\/annonc\/mdr613","journal-title":"Ann Oncol"},{"key":"5562_CR35","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-08-1005","volume":"18","author":"JM Dolle","year":"2009","unstructured":"Dolle JM, Daling JR, White E et al (2009) Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 18:1157\u20131166. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-1005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5562_CR36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10549-011-1616-x","volume":"130","author":"MM Gaudet","year":"2011","unstructured":"Gaudet MM, Press MF, Haile RW et al (2011) Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat 130:587\u2013597. https:\/\/doi.org\/10.1007\/s10549-011-1616-x","journal-title":"Breast Cancer Res Treat"},{"key":"5562_CR37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10549-012-2365-1","volume":"137","author":"CI Li","year":"2013","unstructured":"Li CI, Beaber EF, Tang MTC et al (2013) Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20\u201344 years of age. Breast Cancer Res Treat 137:579\u2013587. https:\/\/doi.org\/10.1007\/s10549-012-2365-1","journal-title":"Breast Cancer Res Treat"},{"key":"5562_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s12672-014-0174-1","volume":"5","author":"AL Scaling","year":"2014","unstructured":"Scaling AL, Prossnitz ER, Hathaway HJ (2014) GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast. Horm Cancer 5:146\u2013160. https:\/\/doi.org\/10.1007\/s12672-014-0174-1","journal-title":"Horm Cancer"},{"key":"5562_CR39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/jnci\/djs505","volume":"105","author":"JM Faupel-Badger","year":"2013","unstructured":"Faupel-Badger JM, Arcaro KF, Balkam JJ et al (2013) Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-Sponsored Workshop. J Natl Cancer Inst 105:166\u2013174. https:\/\/doi.org\/10.1093\/jnci\/djs505","journal-title":"J Natl Cancer Inst"},{"key":"5562_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/0008-5472.CAN-09-3460","volume":"70","author":"H Ma","year":"2010","unstructured":"Ma H, Wang Y, Sullivan-Halley J et al (2010) Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women\u2019s contraceptive and reproductive experiences study. Cancer Res 70:575\u2013587. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3460","journal-title":"Cancer Res"},{"key":"5562_CR41","volume-title":"Encuesta Nacional de la Din\u00e1mica Demogr\u00e1fica 2009. Metodolog\u00eda y tabulados b\u00e1sicos","author":"Instituto Nacional de Estad\u00edstica y Geograf\u00eda","year":"2010","unstructured":"Instituto Nacional de Estad\u00edstica y Geograf\u00eda (2010) Encuesta Nacional de la Din\u00e1mica Demogr\u00e1fica 2009. Metodolog\u00eda y tabulados b\u00e1sicos. Aguascalientes"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05562-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-020-05562-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05562-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:36:19Z","timestamp":1613867779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-020-05562-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,22]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["5562"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05562-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,22]]},"assertion":[{"value":"31 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study participants were in accordance with the ethical standards of the research committee of the National Institute of Public Health (Mexico), and with the 1964 Helsinki declaration and its later amendment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}